Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

60.72
BATS BZX Real-Time Price
As of 10:53am ET
 +0.41 / +0.68%
Today’s Change
45.28
Today|||52-Week Range
60.84
+13.43%
Year-to-Date
4 Large-Cap Drug Stocks To Buy Post Q1 Earnings
May 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close60.31
Today’s open60.73
Day’s range60.56 - 60.84
Volume34,254
Average volume (3 months)3,368,079
Market cap$29.6B
Dividend yield0.69%
Data as of 10:53am ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+19.28%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+2.58%
P/E ratio35.3
Price/Sales5.46
Price/Book19.99

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.70-0.59%
BAXBaxter International...+0.16+0.28%
INCYIncyte Corp+0.65+0.48%
ALXNAlexion Pharmaceutic...-9.29-8.05%
Data as of 10:53am ET, 05/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.53
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts